$XCRT Xcelerate, Inc. Announces Commencement of th
Post# of 25322
(Total Views: 74)
Posted On: 08/22/2024 1:23:55 PM
$XCRT Xcelerate, Inc. Announces Commencement of the Nationalization Process for its PCT International Patent Applications
https://www.accesswire.com/905830/xcelerate-i...plications
MAULDIN, SC / ACCESSWIRE / August 22, 2024 / Xcelerate, Inc. (OTCQB:"XCRT"
today announced the commencement of the nationalization process for its two PCT international patent applications, PCT/US2023/015755 and PCT/US2023/016194. These international patents correspond to the US utility patent applications US 18/187,352 and US 18/189,441 filed with the United States Patent and Trademark Office (USPTO). The key innovation provided by these patents is the introduction of a new "first-person view" to the surgical theatre. This technology integrates cameras directly into surgical tools in order to allow the surgeon to follow and perform the procedure from his tool's perspective. We believe this introduction of the "first-person view" has the potential to significantly boost the precision and speed of a surgical procedure, as well as reducing the size of the surgical site. As an additional potential benefit, the technology integrates surgical site illumination and allows for the projection of targeting markers.
Mike O'Shea, Xcelerate's CEO stated "In addition to our efforts to uplist our common stock for listing on Nasdaq, we are also focusing on the nationalization of our medical device patents. The nationalization of these patents is a significant advancement in Xcelerate's mission to leverage non-medical engineering advancements and intellectual property for clinical and medical care. Mr. O'Shea continued by stating "We are looking forward to using the European Unitary Patent Application Process for the first time. Unitary Patent Applications have been possible since June 2023 and allow filers to cover 17 member states of the European Union (EU) with a single application. This includes the EU's three largest economies: Germany, France, and Italy. Other markets which will be covered include China, Ireland, Japan, and Mexico."
https://www.accesswire.com/905830/xcelerate-i...plications
MAULDIN, SC / ACCESSWIRE / August 22, 2024 / Xcelerate, Inc. (OTCQB:"XCRT"
today announced the commencement of the nationalization process for its two PCT international patent applications, PCT/US2023/015755 and PCT/US2023/016194. These international patents correspond to the US utility patent applications US 18/187,352 and US 18/189,441 filed with the United States Patent and Trademark Office (USPTO). The key innovation provided by these patents is the introduction of a new "first-person view" to the surgical theatre. This technology integrates cameras directly into surgical tools in order to allow the surgeon to follow and perform the procedure from his tool's perspective. We believe this introduction of the "first-person view" has the potential to significantly boost the precision and speed of a surgical procedure, as well as reducing the size of the surgical site. As an additional potential benefit, the technology integrates surgical site illumination and allows for the projection of targeting markers. Mike O'Shea, Xcelerate's CEO stated "In addition to our efforts to uplist our common stock for listing on Nasdaq, we are also focusing on the nationalization of our medical device patents. The nationalization of these patents is a significant advancement in Xcelerate's mission to leverage non-medical engineering advancements and intellectual property for clinical and medical care. Mr. O'Shea continued by stating "We are looking forward to using the European Unitary Patent Application Process for the first time. Unitary Patent Applications have been possible since June 2023 and allow filers to cover 17 member states of the European Union (EU) with a single application. This includes the EU's three largest economies: Germany, France, and Italy. Other markets which will be covered include China, Ireland, Japan, and Mexico."
(0)
(0)Scroll down for more posts ▼